Foghorn Therapeutics Inc.
Develops medicines targeting the chromatin regulatory system for oncology.
FHTX | US
Overview
Corporate Details
- ISIN(s):
- US3441741077
- LEI:
- Country:
- United States of America
- Address:
- 500 TECHNOLOGY SQUARE, 2139 CAMBRIDGE
- Website:
- https://foghorntx.com/
Description
Foghorn Therapeutics Inc. is a biopharmaceutical company pioneering a new class of medicines that target the chromatin regulatory system to treat serious diseases. The company's approach focuses on correcting abnormal gene expression, a key driver in many illnesses. The chromatin regulatory system orchestrates which genes are turned on or off by modifying the 3D structure of DNA. Foghorn develops precision therapeutic candidates designed to address genetically determined dependencies within this system. The primary therapeutic area of focus is oncology, as breakdowns in chromatin regulation are associated with more than half of all cancers. The company also explores applications for its platform in other diseases, including neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Foghorn Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Foghorn Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Foghorn Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
